Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Circ Res
2013 Jun 21;1131:22-31. doi: 10.1161/CIRCRESAHA.113.301324.
Show Gene links
Show Anatomy links
Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development.
Kang Y
,
Kim J
,
Anderson JP
,
Wu J
,
Gleim SR
,
Kundu RK
,
McLean DL
,
Kim JD
,
Park H
,
Jin SW
,
Hwa J
,
Quertermous T
,
Chun HJ
.
???displayArticle.abstract???
The peptide ligand apelin and its receptor APJ constitute a signaling pathway with numerous effects on the cardiovascular system, including cardiovascular development in model organisms such as xenopus and zebrafish. This study aimed to characterize the embryonic lethal phenotype of the Apj-/- mice and to define the involved downstream signaling targets. We report the first characterization of the embryonic lethality of the Apj-/- mice. More than half of the expected Apj-/- embryos died in utero because of cardiovascular developmental defects. Those succumbing to early embryonic death had markedly deformed vasculature of the yolk sac and the embryo, as well as poorly looped hearts with aberrantly formed right ventricles and defective atrioventricular cushion formation. Apj-/- embryos surviving to later stages demonstrated incomplete vascular maturation because of a deficiency of vascular smooth muscle cells and impaired myocardial trabeculation and ventricular wall development. The molecular mechanism implicates a novel, noncanonical signaling pathway downstream of apelin-APJ involving Gα13, which induces histone deacetylase (HDAC) 4 and HDAC5 phosphorylation and cytoplasmic translocation, resulting in activation of myocyte enhancer factor 2. Apj-/- mice have greater endocardial Hdac4 and Hdac5 nuclear localization and reduced expression of the myocyte enhancer factor 2 (MEF2) transcriptional target Krüppel-like factor 2. We identify a number of commonly shared transcriptional targets among apelin-APJ, Gα13, and MEF2 in endothelial cells, which are significantly decreased in the Apj-/- embryos and endothelial cells. Our results demonstrate a novel role for apelin-APJ signaling as a potent regulator of endothelial MEF2 function in the developing cardiovascular system.
???displayArticle.pubmedLink???
23603510
???displayArticle.pmcLink???PMC3739451 ???displayArticle.link???Circ Res ???displayArticle.grants???[+]
Chandra,
Disruption of the apelin-APJ system worsens hypoxia-induced pulmonary hypertension.
2011, Pubmed
Chandra,
Disruption of the apelin-APJ system worsens hypoxia-induced pulmonary hypertension.
2011,
Pubmed
Charo,
Endogenous regulation of cardiovascular function by apelin-APJ.
2009,
Pubmed
Cheng,
Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats.
2003,
Pubmed
Chun,
Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis.
2008,
Pubmed
Cox,
Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo.
2006,
Pubmed
,
Xenbase
Devic,
Amino acid sequence and embryonic expression of msr/apj, the mouse homolog of Xenopus X-msr and human APJ.
1999,
Pubmed
,
Xenbase
Griffin,
A role for thrombin receptor signaling in endothelial cells during embryonic development.
2001,
Pubmed
Inui,
Xapelin and Xmsr are required for cardiovascular development in Xenopus laevis.
2006,
Pubmed
,
Xenbase
Ishida,
Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo.
2004,
Pubmed
Kälin,
Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis.
2007,
Pubmed
,
Xenbase
Kawamata,
Molecular properties of apelin: tissue distribution and receptor binding.
2001,
Pubmed
Kidoya,
Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis.
2008,
Pubmed
Kim,
An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension.
2013,
Pubmed
Kleinz,
Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells.
2005,
Pubmed
Kleinz,
Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells.
2004,
Pubmed
Kuba,
Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload.
2007,
Pubmed
Lee,
Characterization of apelin, the ligand for the APJ receptor.
2000,
Pubmed
Lin,
Requirement of the MADS-box transcription factor MEF2C for vascular development.
1998,
Pubmed
Lin,
Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C.
1997,
Pubmed
Liu,
Galpha13 regulates MEF2-dependent gene transcription in endothelial cells: role in angiogenesis.
2009,
Pubmed
Loot,
A novel APJ signaling cascade that regulates cardiovascular development.
2013,
Pubmed
Lu,
Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases.
2000,
Pubmed
Masri,
Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein.
2002,
Pubmed
McKinsey,
Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation.
2000,
Pubmed
McLean,
Apelin/APJ signaling is a critical regulator of statin effects in vascular endothelial cells--brief report.
2012,
Pubmed
Naya,
Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor.
2002,
Pubmed
O'Dowd,
A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11.
1993,
Pubmed
Offermanns,
Vascular system defects and impaired cell chemokinesis as a result of Galpha13 deficiency.
1997,
Pubmed
Parmar,
Statins exert endothelial atheroprotective effects via the KLF2 transcription factor.
2005,
Pubmed
Parmar,
Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2.
2006,
Pubmed
Paskaradevan,
The Aplnr GPCR regulates myocardial progenitor development via a novel cell-non-autonomous, Gα(i/o) protein-independent pathway.
2012,
Pubmed
Quertermous,
Apelin and its g protein-coupled receptor regulate cardiac development as well as cardiac function.
2007,
Pubmed
Roberts,
Abnormal fluid homeostasis in apelin receptor knockout mice.
2009,
Pubmed
Ruppel,
Essential role for Galpha13 in endothelial cells during embryonic development.
2005,
Pubmed
Scimia,
APJ acts as a dual receptor in cardiac hypertrophy.
2012,
Pubmed
Scott,
The g protein-coupled receptor agtrl1b regulates early development of myocardial progenitors.
2007,
Pubmed
,
Xenbase
Sen-Banerjee,
Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells.
2005,
Pubmed
Sheikh,
In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure.
2008,
Pubmed
Sierro,
Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7.
2007,
Pubmed
Sohn,
Transcriptional regulation of tissue-specific genes by the ERK5 mitogen-activated protein kinase.
2005,
Pubmed
Szokodi,
Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility.
2002,
Pubmed
Tatemoto,
Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor.
1998,
Pubmed
Tatemoto,
The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism.
2001,
Pubmed
Wang,
Fluid shear stress stimulates phosphorylation-dependent nuclear export of HDAC5 and mediates expression of KLF2 and eNOS.
2010,
Pubmed
Yu,
The chemokine receptor CXCR7 functions to regulate cardiac valve remodeling.
2011,
Pubmed
Zeng,
Apelin and its receptor control heart field formation during zebrafish gastrulation.
2007,
Pubmed
,
Xenbase
